Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 694Neoplasms 612Prostatic Neoplasms 315Lung Neoplasms 308Colorectal Neoplasms 280Carcinoma, Non-Small-Cell Lung 254Pancreatic Neoplasms 178Carcinoma, Hepatocellular 168Stomach Neoplasms 139Multiple Myeloma 127Ovarian Neoplasms 120Melanoma 118Colonic Neoplasms 112Brain Neoplasms 108Hematologic Neoplasms 107Head and Neck Neoplasms 106Urinary Bladder Neoplasms 103Leukemia, Myeloid, Acute 102Esophageal Neoplasms 101Disease 100Uterine Cervical Neoplasms 88Neoplasm Metastasis 88Liver Neoplasms 88Rectal Neoplasms 85Lymphoma 84Precursor Cell Lymphoblastic Leukemia-Lymphoma 83Endometrial Neoplasms 76Carcinoma, Renal Cell 73Leukemia 63Recurrence 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) × 1 year × Clear all
NCT06019676 2025-09-18

ADAPT-P

Royal Marsden NHS Foundation Trust

Active not recruiting
170 enrolled
Genitourinary

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡